NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -27.74% | 1.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -27.75% | 1.21% | |||
| Cost of Revenue | -5.30% | -11.36% | |||
| Gross Profit | -38.54% | 8.61% | |||
| SG&A Expenses | -30.97% | -24.39% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.75% | -11.25% | |||
| Operating Income | 42.64% | 28.62% | |||
| Income Before Tax | 15.05% | -44.48% | |||
| Income Tax Expenses | 157.45% | -227.03% | |||
| Earnings from Continuing Operations | 14.29% | -42.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.29% | -42.84% | |||
| EBIT | 42.64% | 28.62% | |||
| EBITDA | 97.61% | 32.21% | |||
| EPS Basic | 56.01% | -42.84% | |||
| Normalized Basic EPS | 72.47% | -39.89% | |||
| EPS Diluted | 56.01% | -42.75% | |||
| Normalized Diluted EPS | 72.47% | -39.89% | |||
| Average Basic Shares Outstanding | 94.84% | 0.00% | |||
| Average Diluted Shares Outstanding | 94.84% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||